- Utah Medical Products (NASDAQ:UTMD -1.4%) Q2 results: Net Sales: $10.5M (+4.9%); Gross Profit: $6.3M (+5.0%); Operating Income: $4.1M (+9.3%); Net Income: $2.8M (+7.6%); EPS: $0.751 (+7.5%); Quick Assets: $16.0M (+10.7%).
- No guidance given.
More on Utah Med Q2 results
Recommended For You
More Trending News
About UTMD Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| UTMD | - | - |
| Utah Medical Products, Inc. | ||